Even though I owned AJX and have done well, I see NEU with much more long term upside, on the proviso of FDA approval. AJX is good, but it will have to keep winning contracts over the long term. NEU should be able to reward it's shareholders by long term sales, with huge margins. There is simply no other product that can help these unfortunate people, and nothing really in the pipeline for the time being. There are 200 ooo people estimated with retts in the US alone.
FDA decision within 1-50 days, page-21
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |